Advertisements

Stocking Stuffers

 

Knight Therapeutics Inc. (GUD:CA) Stock Quote

Detailed Quote for Knight Therapeutics Inc. (GUD:CA)
$ 7.46   -0.22 (-2.86%) Volume: 422.84k 4:16 PM EDT Mar 22, 2019
Today 5d 1m 3m 1y more
Last Price
7.46
Change $
0.22
Change %
2.86%
Tick
  
Bid
7.44
Bid Size
2,700
Ask
7.60
Ask Size
300
Open
7.64
High
7.65
Low
7.43
Prev Close
7.68
Last Trade
03/22/19
Volume
422.84k
52 Wk Hi
8.81000041
52 Wk Low
7.3499999
Market Cap
1.07b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
142,850,512
EPS (TTM)
0.170000001
PE Ratio
44.70
Exchange
TSX
News and Media for Knight Therapeutics Inc. (GUD:CA)
Sector News | Topic News
News for Knight Therapeutics Inc. (GUD:CA)
Thu, Mar 21, 2019
8:00 AM Knight Therapeutics Initiates Legal Action Against Medison Biotech to Protect the Interests of Knight Shareholders - GlobeNewswire
Fri, Mar 15, 2019
7:40 AM Knight Therapeutics Responds to Shareholder Discontent By Targeting Medison Biotech, Knight's Second Largest Shareholder - GlobeNewswire
Thu, Mar 14, 2019
8:30 PM Knight Addresses Misleading and Self-Serving Plan Issued by Disgruntled Director - GlobeNewswire
8:00 AM Knight Therapeutics' Second Largest Shareholder Presents Strategy to Create Shareholder Value - GlobeNewswire
6:00 AM Knight Reports 2018 Fourth Quarter and Year End Results - GlobeNewswire
Thu, Mar 07, 2019
5:01 PM Notice of Knight Therapeutics' 2018 Fourth Quarter and Year End Results Conference Call - GlobeNewswire
Thu, Feb 28, 2019
4:53 PM Knight Therapeutics Comments on Flawed Accusations by Disgruntled Board Member; Remains Committed to Executing Strategy that is Working - GlobeNewswire
Wed, Feb 20, 2019
4:05 PM Knight Therapeutics and Triumvira Immunologics Triumphantly Announce Secured Bridge Loan & License Agreement - GlobeNewswire
Mon, Feb 18, 2019
8:30 AM Knight Signs GUD (Bueno) Latin American Strategic Funding Deal with Moksha8 - GlobeNewswire
Fri, Jan 11, 2019
8:00 AM Knight Therapeutics Runs with Exclusive Canadian License to Puma's NERLYNX\u00AE - GlobeNewswire
Tue, Dec 11, 2018
7:45 AM Today's Research Reports on IntelliPharmaCeutics International, Centric Health, Knight Therapeutics and Oncolytics Biotech - ACCESSWIRE IA
Mon, Nov 26, 2018
4:30 PM Knight Therapeutics Announces Canadian Regulatory Approval for ILUVIEN\u00AE - GlobeNewswire
Thu, Nov 08, 2018
6:00 AM Knight Therapeutics Reports Third Quarter 2018 Results - GlobeNewswire
Thu, Nov 01, 2018
8:00 AM Notice of Knight Therapeutics' Third Quarter 2018 Results Conference Call - GlobeNewswire
Mon, Oct 29, 2018
8:00 AM Knight Therapeutics Announces the Canadian launch of PROBUPHINE(TM) for Opioid Use Disorder - GlobeNewswire
8:00 AM Today's Research Reports on Knight Therapeutics, Covalon Technologies, Titan Medical and Neovasc - ACCESSWIRE IA
Tue, Sep 25, 2018
8:00 AM Knight to Present at the Cantor Fitzgerald Global Healthcare Conference in New York City - GlobeNewswire
Mon, Sep 24, 2018
4:36 PM Knight Therapeutics and Jaguar Health Announce Strategic Partnership - GlobeNewswire
4:30 PM Knight Therapeutics and Jaguar Health Announce Strategic Partnership - ACCESSWIRE
8:00 AM Today's Research Reports on Aurinia Pharmaceuticals, Canopy Growth, Knight Therapeutics and Covalon Technologies - ACCESSWIRE IA
More News for GUD:CA >>

Tags for Knight Therapeutics Inc.

Research stocks or mutual funds related to Knight Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to GUD:CA. The keywords below have been associated to GUD:CA by either user submission or electronic means.